Title: Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.
Citation: Ann Med
2024;56:2317356.
Country: Spain | Indication: Asthma
Scan to access the publication or visit
http://tago.ca/38364218
http://tago.ca/38364218